These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 38458124)

  • 1. Improving newborn screening test performance for metachromatic leukodystrophy: Recommendation from a pre-pilot study that identified a late-infantile case for treatment.
    Wu THY; Brown HA; Church HJ; Kershaw CJ; Hutton R; Egerton C; Cooper J; Tylee K; Cohen RN; Gokhale D; Ram D; Morton G; Henderson M; Bigger BW; Jones SA
    Mol Genet Metab; 2024 May; 142(1):108349. PubMed ID: 38458124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lentiviral haematopoietic stem-cell gene therapy for early-onset metachromatic leukodystrophy: long-term results from a non-randomised, open-label, phase 1/2 trial and expanded access.
    Fumagalli F; Calbi V; Natali Sora MG; Sessa M; Baldoli C; Rancoita PMV; Ciotti F; Sarzana M; Fraschini M; Zambon AA; Acquati S; Redaelli D; Attanasio V; Miglietta S; De Mattia F; Barzaghi F; Ferrua F; Migliavacca M; Tucci F; Gallo V; Del Carro U; Canale S; Spiga I; Lorioli L; Recupero S; Fratini ES; Morena F; Silvani P; Calvi MR; Facchini M; Locatelli S; Corti A; Zancan S; Antonioli G; Farinelli G; Gabaldo M; Garcia-Segovia J; Schwab LC; Downey GF; Filippi M; Cicalese MP; Martino S; Di Serio C; Ciceri F; Bernardo ME; Naldini L; Biffi A; Aiuti A
    Lancet; 2022 Jan; 399(10322):372-383. PubMed ID: 35065785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toward newborn screening of metachromatic leukodystrophy: results from analysis of over 27,000 newborn dried blood spots.
    Hong X; Daiker J; Sadilek M; Ruiz-Schultz N; Kumar AB; Norcross S; Dansithong W; Suhr T; Escolar ML; Ronald Scott C; Rohrwasser A; Gelb MH
    Genet Med; 2021 Mar; 23(3):555-561. PubMed ID: 33214709
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predicting clinical phenotypes of metachromatic leukodystrophy based on the arylsulfatase A activity and the ARSA genotype? - Chances and challenges.
    Santhanakumaran V; Groeschel S; Harzer K; Kehrer C; Elgün S; Beck-Wödl S; Hengel H; Schöls L; Haack TB; Krägeloh-Mann I; Laugwitz L
    Mol Genet Metab; 2022 Nov; 137(3):273-282. PubMed ID: 36240581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The importance of early diagnosis and views on newborn screening in metachromatic leukodystrophy: results of a Caregiver Survey in the UK and Republic of Ireland.
    Morton G; Thomas S; Roberts P; Clark V; Imrie J; Morrison A
    Orphanet J Rare Dis; 2022 Nov; 17(1):403. PubMed ID: 36329444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Higher precision, first tier newborn screening for metachromatic leukodystrophy using 16:1-OH-sulfatide.
    Bekri S; Bley A; Brown HA; Chanson C; Church HJ; Gelb MH; Hong X; Janzen N; Kasper DC; Mechtler T; Morton G; Murko S; Oliva P; Tebani A; Wu THY
    Mol Genet Metab; 2024 May; 142(1):108436. PubMed ID: 38552449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atidarsagene autotemcel for metachromatic leukodystrophy.
    Messina M; Gissen P
    Drugs Today (Barc); 2023 Feb; 59(2):63-70. PubMed ID: 36811406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metachromatic Leukodystrophy (MLD): a Pakistani Family with Novel ARSA Gene Mutation.
    Shahzad MA; Khaliq S; Amar A; Mahmood S
    J Mol Neurosci; 2017 Sep; 63(1):84-90. PubMed ID: 28799099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Understanding caregiver descriptions of initial signs and symptoms to improve diagnosis of metachromatic leukodystrophy.
    Eichler F; Sevin C; Barth M; Pang F; Howie K; Walz M; Wilds A; Calcagni C; Chanson C; Campbell L
    Orphanet J Rare Dis; 2022 Oct; 17(1):370. PubMed ID: 36195888
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Consensus guidelines for the monitoring and management of metachromatic leukodystrophy in the United States.
    Adang LA; Bonkowsky JL; Boelens JJ; Mallack E; Ahrens-Nicklas R; Bernat JA; Bley A; Burton B; Darling A; Eichler F; Eklund E; Emrick L; Escolar M; Fatemi A; Fraser JL; Gaviglio A; Keller S; Patterson MC; Orchard P; Orthmann-Murphy J; Santoro JD; Schöls L; Sevin C; Srivastava IN; Rajan D; Rubin JP; Van Haren K; Wasserstein M; Zerem A; Fumagalli F; Laugwitz L; Vanderver A
    Cytotherapy; 2024 Jul; 26(7):739-748. PubMed ID: 38613540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metachromatic leukodystrophy genotypes in The Netherlands reveal novel pathogenic ARSA variants in non-Caucasian patients.
    Beerepoot S; van Dooren SJM; Salomons GS; Boelens JJ; Jacobs EH; van der Knaap MS; van Kuilenburg ABP; Wolf NI
    Neurogenetics; 2020 Oct; 21(4):289-299. PubMed ID: 32632536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genotypic characterization of Brazilian patients with infantile and juvenile forms of metachromatic leukodystrophy.
    Virgens MY; Siebert M; Bock H; Burin M; Giugliani R; Saraiva-Pereira ML
    Gene; 2015 Aug; 568(1):69-75. PubMed ID: 25965562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A systematic review of clinical effectiveness and safety for historical and current treatment options for metachromatic leukodystrophy in children, including atidarsagene autotemcel.
    Armstrong N; Olaye A; Noake C; Pang F
    Orphanet J Rare Dis; 2023 Aug; 18(1):248. PubMed ID: 37644601
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toward Reference Intervals of ARSA Activity in the Cerebrospinal Fluid: Implication for the Clinical Practice of Metachromatic Leukodystrophy.
    Morena F; Argentati C; Acquati S; DeWall S; Kelly F; Calbi V; Fumagalli F; Zancan S; Biffi A; Aiuti A; Martino S
    J Appl Lab Med; 2021 Mar; 6(2):354-366. PubMed ID: 32910180
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of a novel splicing mutation in the ARSA gene in a patient with late-infantile form of metachromatic leukodystrophy.
    Kang DH; Lee DH; Hong YH; Lee ST; Jeon BR; Lee YK; Ki CS; Lee YW
    Korean J Lab Med; 2010 Oct; 30(5):516-20. PubMed ID: 20890085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Molecular screening of the major mutations in the ARSA gene in patients with metachromatic leukodystrophy].
    Horovenko NH; Ol'khovych NV; Pichkur NO
    Tsitol Genet; 2002; 36(5):43-8. PubMed ID: 12442547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biochemical and molecular analysis of pediatric patients with metachromatic leukodystrophy in South China: functional characterization of five novel ARSA variants.
    Li T; Huang Y; Tao C; Yin X; Su X; Shao Y; Liang C; Jiang M; Cai Y; Lin Y; Zeng C; Zhao X; Liu L; Zhang W
    Metab Brain Dis; 2024 Jun; 39(5):753-762. PubMed ID: 38775997
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chinese Cases of Metachromatic Leukodystrophy with the Novel Missense Mutations in ARSA Gene.
    Wu S; Hou M; Zhang Y; Song J; Guo Y; Liu P; Liu Y; Yi L; Pan X; We W; Chen Z
    J Mol Neurosci; 2021 Feb; 71(2):245-251. PubMed ID: 32617873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generation of Human Induced Pluripotent Stem Cell-Derived Bona Fide Neural Stem Cells for Ex Vivo Gene Therapy of Metachromatic Leukodystrophy.
    Meneghini V; Frati G; Sala D; De Cicco S; Luciani M; Cavazzin C; Paulis M; Mentzen W; Morena F; Giannelli S; Sanvito F; Villa A; Bulfone A; Broccoli V; Martino S; Gritti A
    Stem Cells Transl Med; 2017 Feb; 6(2):352-368. PubMed ID: 28191778
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A retrospective cohort study of Libmeldy (atidarsagene autotemcel) for MLD: What we have accomplished and what opportunities lie ahead.
    Horgan C; Watts K; Ram D; Rust S; Hutton R; Jones S; Wynn R
    JIMD Rep; 2023 Sep; 64(5):346-352. PubMed ID: 37701322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.